Back to Journals » OncoTargets and Therapy » Volume 9

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer

Total article views   Abstract views HTML views PDF downloads Totals
8,338 Dovepress* 3,973 1,408+ 879 5,381
PubMed Central* 0 2,957 850 2,957
Totals 3,973 4,365 1,729 8,338
*Since 20 October 2016
+Since July 2016

View citations on PubMed Central and Google Scholar